Home [sandbox] K4D COVID-19 Resource Hub Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial

Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 2020-09-23

Link:

https://api.zotero.org/groups/2494380/items/DSXD6V9W?format=atom

Updated:

09/23/2020, 09:49

From feeds:

[sandbox] K4D COVID-19 Resource Hub ยป Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items

Tags:

Authors:

jimwoodhill

Date tagged:

09/23/2020, 10:07

Date published:

09/23/2020, 09:47